Osmotic agents in injectables and dialysis

The aim of intravenous treatments is to optimize the balance of fluids, energy, nitrogen and electrolytes in the blood by the infusion of appropriate solutions. As with all parenteral applications, ensuring the solution is pyrogen-free is vital.

Our plants operate a dedicated production channel for pharmaceutical-grade dextrose monohydrate and mannitol for intravenous injections. The plant facilities have been audited by most of the producers of solutions of parenteral infusion and hemodialysis worldwide. Cargill was approved as a qualified supplier in all cases.

Product	Brandname
Monohydrouse dextrose	CPharmDex™